-
-
-
-
-
-
-
Piper Sandler Starts Palisade Bio Inc. (PALI) at Overweight
-
-
-
-
-
-
-
Palisade Bio names Emil Chuang to board of directors
-
-
-
-
-
-
-
Palisade Bio Inc. (PALI) Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis
-
-
-
-
-
-
-
Palisade Bio (PALI) Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis
-
-
-
-
-
-
-
Palisade Bio (PALI) Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

